NSE · FDC.NS
FDC Limited
₹379.00+₹1.85 (+0.49%)
FDC Limited’s quoted price sits in the lower half of its reported 52-week range, 19.97% below the high.
Loading market information…
BSE · KPL.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 06:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Kwality Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kwality Pharmaceuticals Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Kwality Pharmaceuticals Ltd. is dedicated to developing and manufacturing a diverse range of pharmaceutical products, presented in various dosage forms. Their extensive portfolio includes items such as tablets, boluses, oral liquid medications, sterile injectable powders, topical ointments, ophthalmic solutions, capsules, liquid injectables, dry powders intended for oral suspensions, and external preparations. The enterprise was established by Ramesh Arora on May 4, 1983, and its principal operations are based in Amritsar, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₹379.00+₹1.85 (+0.49%)
FDC Limited’s quoted price sits in the lower half of its reported 52-week range, 19.97% below the high.
₹76.80+₹1.81 (+2.41%)
Shukra Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 0.26% below the high.
₹204.91-₹4.23 (-2.02%)
Kilitch Drugs (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 23.51% below the high.
₹262.15-₹4.80 (-1.8%)
Medicamen Biotech Limited’s quoted price sits in the lower half of its reported 52-week range, 41.44% below the high.
₹414.45+₹14.15 (+3.53%)
BDH Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 32.06% below the high.
₹18.69-₹0.29 (-1.53%)
Medico Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 67.14% below the high.
₹84.90₹0.00 (0.0%)
Quest Laboratories Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.36% below the high.
₹63.03-₹2.96 (-4.49%)
Concord Drugs Limited’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
